These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31952833)

  • 1. Bioengineered 3D Models to Recapitulate Tissue Fibrosis.
    Sacchi M; Bansal R; Rouwkema J
    Trends Biotechnol; 2020 Jun; 38(6):623-636. PubMed ID: 31952833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.
    Portillo-Lara R; Spencer AR; Walker BW; Shirzaei Sani E; Annabi N
    Biomaterials; 2019 Apr; 198():78-94. PubMed ID: 30201502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering for Organ Transplantation: Progress and Challenges.
    Welman T; Michel S; Segaren N; Shanmugarajah K
    Bioengineered; 2015; 6(5):257-61. PubMed ID: 26259720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.
    Nam KH; Smith AS; Lone S; Kwon S; Kim DH
    J Lab Autom; 2015 Jun; 20(3):201-15. PubMed ID: 25385716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Surface Engineering Tools for Programming Living Assemblies.
    Almeida-Pinto J; Lagarto MR; Lavrador P; Mano JF; Gaspar VM
    Adv Sci (Weinh); 2023 Dec; 10(34):e2304040. PubMed ID: 37823678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model.
    Chang R; Emami K; Wu H; Sun W
    Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioengineering heart tissue for in vitro testing.
    Cimetta E; Godier-Furnémont A; Vunjak-Novakovic G
    Curr Opin Biotechnol; 2013 Oct; 24(5):926-32. PubMed ID: 23932513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering three-dimensional microenvironments towards in vitro disease models of the central nervous system.
    Yildirimer L; Zhang Q; Kuang S; Cheung CJ; Chu KA; He Y; Yang M; Zhao X
    Biofabrication; 2019 Jun; 11(3):032003. PubMed ID: 30965297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-engineered kidney disease models.
    Desrochers TM; Palma E; Kaplan DL
    Adv Drug Deliv Rev; 2014 Apr; 69-70():67-80. PubMed ID: 24361391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered Kidney Models: Methods and Functional Assessments.
    Rizki-Safitri A; Traitteur T; Morizane R
    Function (Oxf); 2021; 2(4):zqab026. PubMed ID: 35330622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coming to terms with tissue engineering and regenerative medicine in the lung.
    Prakash YS; Tschumperlin DJ; Stenmark KR
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(7):L625-38. PubMed ID: 26254424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered human cardiac tissues for modeling heart diseases.
    Min S; Cho SW
    BMB Rep; 2023 Jan; 56(1):32-42. PubMed ID: 36443005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced 3D
    Jain N; Shashi Bhushan BL; Natarajan M; Mehta R; Saini DK; Chatterjee K
    ACS Biomater Sci Eng; 2024 Mar; 10(3):1235-1261. PubMed ID: 38335198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-inspired 3D microenvironments: a new dimension in tissue engineering.
    Magin CM; Alge DL; Anseth KS
    Biomed Mater; 2016 Mar; 11(2):022001. PubMed ID: 26942469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying Activated Fibroblast Phenotypes and Fibrosis-Linked Mechanosensing Using 3D Biomimetic Models.
    Paradiso F; Quintela M; Lenna S; Serpelloni S; James D; Caserta S; Conlan S; Francis L; Taraballi F
    Macromol Biosci; 2022 Apr; 22(4):e2100450. PubMed ID: 35014177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.
    Peck Y; Wang DA
    Expert Opin Drug Deliv; 2013 Mar; 10(3):369-83. PubMed ID: 23289593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D Bioprinting of Human Tissues: Biofabrication, Bioinks, and Bioreactors.
    Zhang J; Wehrle E; Rubert M; Müller R
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization of decellularized lung scaffolds: principles and progress.
    Stabler CT; Lecht S; Mondrinos MJ; Goulart E; Lazarovici P; Lelkes PI
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(11):L1273-85. PubMed ID: 26408553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrotic microtissue array to predict anti-fibrosis drug efficacy.
    Asmani M; Velumani S; Li Y; Wawrzyniak N; Hsia I; Chen Z; Hinz B; Zhao R
    Nat Commun; 2018 May; 9(1):2066. PubMed ID: 29802256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.